Pathstone Family Office’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$548K Buy
54,306
+31,278
+136% +$326K ﹤0.01% 1000
2023
Q2
$242K Buy
23,028
+3,374
+17% +$32.2K ﹤0.01% 1065
2023
Q1
$206K Sell
19,654
-38,822
-66% -$431K ﹤0.01% 1081
2022
Q4
$11.9M Buy
58,476
+16,202
+38% +$169K 0.1% 156
2022
Q3
$381K Buy
42,274
+24,492
+138% +$241K ﹤0.01% 1170
2022
Q2
$186K Buy
+17,782
New +$195K ﹤0.01% 968
2021
Q1
Sell
-8,905
Closed -$167K 1338
2020
Q4
$167K Buy
+8,905
New +$145K 0.01% 285
2017
Q2
Sell
-20
Closed -$1K 645
2017
Q1
$1K Buy
+20
New +$806 ﹤0.01% 530
2015
Q4
Sell
-350
Closed -$14K 165
2015
Q3
$14K Buy
+350
New +$19.5K 0.04% 66

Other funds holding VTRS

Pathstone Family Office's VTRS Position: Q3 2023 in Review

Pathstone Family Office increased its Viatris (VTRS) stake by 136% in Q3 2023, buying an estimated $326K and bringing the position to 54,306 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

Pathstone Family Office first reported a position in VTRS in Q3 2015 and has held it in 9 quarters since. The position peaked at $11.9M in Q4 2022. 960 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

  • Pathstone Family Office held 54,306 shares of Viatris worth $548K as of Q3 2023.
  • Pathstone Family Office bought 31,278 Viatris shares in Q3 2023, an estimated $326K.
  • Viatris made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1000 holding.
  • Pathstone Family Office first reported a position in Viatris in Q3 2015 and has held it in 9 quarters since.
  • Pathstone Family Office's Viatris position peaked at $11.9M in Q4 2022.
  • 960 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.